Abstract

Patients with Parkinson’s disease often complain of excessive daytime sleepiness which negatively impacts their quality of life. The pedunculopontine nucleus, proposed as a target for deep brain stimulation to improve freezing of gait in Parkinson’s disease, is also known to play a key role in the arousal system. Thus, the putative control of excessive daytime sleepiness by pedunculopontine nucleus area stimulation merits exploration for treating Parkinson’s disease patients. To this end, two adult nonhuman primates (macaca fascicularis) received a deep brain stimulation electrode implanted into the pedunculopontine nucleus area along with a polysomnographic equipment. Stimulation at low frequencies and high frequencies was studied, in healthy and then MPTP-treated nonhuman primates. Here, we observed that MPTP-treated nonhuman primates suffered from excessive daytime sleepiness and that low-frequency stimulation of the pedunculopontine nucleus area was effective in reducing daytime sleepiness. Indeed, low-frequency stimulation of the pedunculopontine nucleus area induced a significant increase in sleep onset latency, longer continuous periods of wakefulness and thus, a partially restored daytime wake architecture. These findings may contribute to the development of new therapeutic strategies in patients suffering from excessive daytime sleepiness.

Details

Title
Excessive daytime sleepiness in a model of Parkinson’s disease improved by low-frequency stimulation of the pedunculopontine nucleus
Author
Davin, Aurélie 1   VIAFID ORCID Logo  ; Chabardès, Stéphan 2 ; Devergnas, Annaelle 3 ; Benstaali, Caroline 4 ; Gutekunst, Claire-Anne N. 5 ; David, Olivier 6 ; Torres-Martinez, Napoléon 7   VIAFID ORCID Logo  ; Piallat, Brigitte 4   VIAFID ORCID Logo 

 Univ. Grenoble Alpes, CEA, LETI, Clinatec, Grenoble, France (GRID:grid.457348.9) (ISNI:0000 0004 0630 1517); Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France (GRID:grid.462307.4) (ISNI:0000 0004 0429 3736) 
 Univ. Grenoble Alpes, CEA, LETI, Clinatec, Grenoble, France (GRID:grid.457348.9) (ISNI:0000 0004 0630 1517); Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France (GRID:grid.462307.4) (ISNI:0000 0004 0429 3736); Univ. Grenoble Alpes, Inserm, Department of Neurosurgery, Grenoble, France (GRID:grid.7429.8) (ISNI:0000000121866389) 
 Yerkes National Primate Research Center, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); Emory University School of Medicine, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502) 
 Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France (GRID:grid.462307.4) (ISNI:0000 0004 0429 3736) 
 Emory University School of Medicine, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502) 
 Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France (GRID:grid.462307.4) (ISNI:0000 0004 0429 3736); Univ. Aix Marseille, Inserm, INS, Institut de Neurosciences des Systèmes, Marseille, France (GRID:grid.462494.9) (ISNI:0000 0004 0541 5643) 
 Univ. Grenoble Alpes, CEA, LETI, Clinatec, Grenoble, France (GRID:grid.457348.9) (ISNI:0000 0004 0630 1517) 
Pages
9
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2768984700
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.